New hope for aggressive brain tumors? triple drug combo under trial
Disease control
Recruiting now
This study tests whether combining three drugs (trimipramine, atezolizumab, and bevacizumab) can help people with recurrent glioblastoma, a fast-growing brain cancer that has returned after standard treatment. About 59 participants will receive the drug combination for up to 2 ye…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC